Onderneming Intellia Therapeutics, Inc.
Aandelen
NTLA
US45826J1051
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
21,28 USD | -1,18% | -1,16% | -30,31% |
15/04 | Intellia Therapeutics, Inc. Stelt Michael P. Dube aan als hoofd boekhouding | CI |
25/03 | Intellia Therapeutics beëindigt ontwikkelingsovereenkomst met Regeneron Pharmaceuticals | MT |
Vakgebied
Aantal werknemers: 526
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Genome Editing-based Therapies
100,0
%
| 52 | 100,0 % | 36 | 100,0 % | -30,40% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 52 | 100,0 % | 36 | 100,0 % | -30,40% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 66 | 01-07-14 |
Glenn Goddard
DFI | Director of Finance/CFO | 53 | 29-10-18 |
Eliana Clark
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
Chief Tech/Sci/R&D Officer | 63 | 28-05-19 | |
David Lebwohl
CTO | Chief Tech/Sci/R&D Officer | 69 | 30-04-20 |
Li Lina
IRC | Investor Relations Contact | - | - |
- | - | ||
Aron Stein
LAW | General Counsel | - | - |
Derek Hicks
PRN | Corporate Officer/Principal | 51 | 20-12-21 |
Marika St Amand
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fred Cohen
BRD | Director/Board Member | 67 | 24-01-19 |
John Leonard
CEO | Chief Executive Officer | 66 | 01-07-14 |
Frank Verwiel
CHM | Chairman | 62 | 24-07-17 |
William Chase
BRD | Director/Board Member | 57 | 14-04-23 |
Jesse Goodman
BRD | Director/Board Member | 72 | 31-10-18 |
Georgia Keresty
BRD | Director/Board Member | 62 | 09-04-21 |
Muna Bhanji
BRD | Director/Board Member | 61 | 28-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 96 106 405 | 94 824 319 ( 98,67 %) | 0 | 98,67 % |
Bedrijfsgegevens
Intellia Therapeutics, Inc.
40 Erie Street Suite 130
02139, Cambridge
+857 285 6200
http://www.intelliatx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-30,31% | 2,08 mld. | |
+3,20% | 43,43 mld. | |
+47,81% | 41,69 mld. | |
+8,45% | 41,31 mld. | |
-10,92% | 27,14 mld. | |
+8,27% | 25,28 mld. | |
-24,42% | 18,47 mld. | |
+29,12% | 12,59 mld. | |
+0,84% | 12,33 mld. | |
+9,04% | 11,03 mld. |
- Beurs
- Aandelen
- Koers NTLA
- Onderneming Intellia Therapeutics, Inc.